Try our mobile app

Published: 2022-01-27 00:00:00 ET
<<<  go to NATI company page
HTTP/1.1 200 OK HTTP/1.1 200 OK X-Crawlera-Slave: 107.174.255.12:3128 X-Crawlera-Version: 1.60.1 accept-ranges: bytes content-type: text/html last-modified: Thu, 27 Jan 2022 21:06:19 GMT server: AmazonS3 x-amz-id-2: qkx4sHaiw0qvGqk/W2FXooY28S9PnNjTAi/QMok4GNEigq9ixMS1k/Oim7WEAz9wHdCDEYhSJsc= x-amz-meta-mode: 33188 x-amz-meta-s3cmd-attrs: uid:504/gname:fitrprnt/uname:fitrprnt/gid:504/mode:33184/mtime:1643317575/atime:1643317575/md5:6c6d51bd3f2e5a1f74bc92ebff2a37f5/ctime:1643317576 x-amz-replication-status: COMPLETED x-amz-request-id: 3A874ZNG4PJQS7G1 x-amz-version-id: gaT7cZFSIeCl7pPcAJTHLk1yc62XeWmD x-content-type-options: nosniff x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-akamai-transformed: 9 24241 0 pmb=mTOE,2 expires: Thu, 06 Apr 2023 19:02:45 GMT cache-control: max-age=0, no-cache, no-store pragma: no-cache date: Thu, 06 Apr 2023 19:02:45 GMT vary: Accept-Encoding akamai-x-true-ttl: -1 strict-transport-security: max-age=31536000 ; includeSubDomains ; preload set-cookie: ak_bmsc=464D1736218F86E7371F3179225F8893~000000000000000000000000000000~YAAQdag8F2hxkDGHAQAA9SXzVxMB6ExnthaRLJ5EAA1te5m+hBJMYp6+tMpZd9L7GbVJlNzmWdUydNxYqYepK5XF8C7BP7E5YI0E97mHH/LhR6jkWGtVWKtdbntEfwxwdshyzJxaMM7mrf9uE3upvU8cE0gBYqxeJ7YrI4TUZDrkVf6S4GLfAj+M4zjWY8YiURB8M4Rh/jHU6y7LNpMvT5vWkFO+DSWFgojZytIbXK4uDrTNGxewsRsEk7JbQ5q1HRR7wRuZsdCUgJx8k1Ijl2qFZCm4qN/QETWR4lICSJ7cdSLAv8cHplVOnVUyGC+SDcOPk7Nm6nDSB8fpFlVibhLV3PCBIRPSXklsmjs8NsT8EjfScaYOALTIZwsN7cGbK74uJ00NdUU=; Domain=.sec.gov; Path=/; Expires=Thu, 06 Apr 2023 21:02:45 GMT; Max-Age=7200; HttpOnly set-cookie: bm_mi=7E4851126013695A032F1906C700D5FD~YAAQdag8F2lxkDGHAQAA9SXzVxNEYYauhnhT5JyfxwX6uhpjFBIfsndGPsS60sQEUfm70+zmC0P0ZACbC3k4RdurPPAlXJ7nObfiIFv2D2cUkrp2vasO5BOMTvd6JydN7z8xvzfpaM638YDzsS0kQPDsyxiBNf52yxwFn+O0HpIlwFjLv0+ps4z/esFkkFgLYFlX7RNQkCR4RrAjH22WA0A8m6qC+W4pI4KxkQKt28CQmnH8glMYG2HqHHtTKoToQYM7Vm8uattDtl1eAvxBS9MYbPb9trXxN5OV3LfDdwhuqvQu4eEAWHqaEqXeMqJSdnOJrkozdUPh3ggdIZApPKBH45AMj5fEkJbDJ2tyf2OhTF25N2Tx4joARIDXn5TocV6fRBOUxQ==~1; Domain=.sec.gov; Path=/; Expires=Thu, 06 Apr 2023 19:02:45 GMT; Max-Age=0; Secure Transfer-Encoding: chunked Proxy-Connection: close Connection: close EX-99.1 2 exhibit99_1.htm EXHIBIT 99.1
 Contact: Marissa Vidaurri
Head of Investor Relations
(512) 683-5215

NI Achieves Record Financial Performance for Q4 and Fiscal Year 2021
NI Board of Directors authorizes $250 million share repurchase program

Q4 2021 Highlights

All-time record revenue of $421 million, up 14 percent year over year

All-time record orders up 19 percent year over year

Strong diluted GAAP EPS of $0.30

All-time record diluted non-GAAP EPS of $0.60

Cash and cash equivalents of $211 million as of December 31, 2021

Returned $66 million to stockholders through stock repurchase and dividends

AUSTIN, Texas - Jan. 27, 2022 - National Instruments Corporation (Nasdaq: NATI) today announced Q4 2021 revenue of $421 million, up 14 percent year over year and an all-time quarterly record.

In Q4 2021, the value of the company’s total orders were  up 19 percent year over year, an all-time quarterly record. Geographic order growth for Q4 2021 compared with Q4 2020 was up 34 percent in the Americas,  down 2 percent in APAC and up 20 percent in EMEA.

In Q4, GAAP gross margin was 71 percent and non-GAAP gross margin was 74 percent. Total Q4 GAAP operating expenses were $247 million, up 1 percent year over year. Total Q4 non-GAAP operating expenses were $214 million, up 9 percent year over year. GAAP operating margin was 12 percent in Q4, with GAAP operating income of $50 million. Non-GAAP operating margin was 23 percent in Q4, with non-GAAP operating income of $96 million, up 22 percent year over year.

GAAP net income for Q4 was $40 million, with diluted earnings per share ("EPS") of $0.30, and non-GAAP net income was $80 million, with non-GAAP diluted EPS of $0.60.

"We delivered the strongest non-GAAP financial performance in our company's history in the fourth quarter with all-time record orders, revenue, operating income, and earnings. We believe 2021 is an inflection point for our business and a direct reflection of the strategic changes we’ve made over the last several years," said Eric Starkloff, NI president and CEO. "The areas where we have focused showed momentum throughout the year with growth across all business units and all regions. We believe we are focused on the right market opportunities and enter 2022 in a position of strength and poised to accelerate growth."

"As we close out the year, I am proud of our performance with revenue and EPS at the high end of guidance. We will continue to be intentional with investments that we believe will accelerate revenue and strengthen our competitive advantage, while continuing to scale our cost structure to increase profitability," said Karen Rapp, NI CFO. "We remain confident in our ability to achieve our 2023 financial model a year ahead of schedule. Our strong balance sheet gives us confidence in the ability to leverage inorganic opportunities to enhance our technology capabilities and expertise while also returning excess cash to stockholders."

As of December 31, 2021, NI had $211 million in cash with $143 million in cash generated from operations in 2021. During Q4, NI paid $36 million in dividends and repurchased approximately 740,000 shares of our common stock at an average price of $40.52 per share. For the year, we returned over $198 million to our stockholders through dividends and stock repurchases, including the repurchase of 1.3 million shares at an average price of $41.06 per share. The NI Board of Directors approved a dividend of $0.28 per share payable on February 28, 2022, to stockholders of record on February 7, 2022. This represents an increase of 4 percent per share.
The NI Board of Directors also authorized a new stock repurchase program for up to $250 million of its common stock. The new stock repurchase program is effective immediately and is in addition to the previously authorized stock repurchase program.

The company’s non-GAAP results exclude, as applicable, the impact of purchase accounting fair value adjustments, stock-based compensation, amortization of acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, restructuring charges, tax reform charges, disposal gains on buildings and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs. Reconciliations of the company’s GAAP and non-GAAP results are included as part of this news release.

FY 2021 Highlights

All-time record revenue of $1.47 billion, up 14 percent year over year

GAAP gross margin of 71 percent

Non-GAAP gross margin of 75 percent

Strong diluted GAAP EPS of $0.67

Record diluted non-GAAP EPS of $1.68

Returned $198 million to stockholders through stock repurchase and dividends

In 2021, GAAP operating expenses were $931 million, up 6 percent year over year, and non-GAAP operating expenses were $824 million, up 9 percent year over year. GAAP net income in 2021 was $89 million, down 38 percent year over year, and non-GAAP net income was $224 million, up 37 percent year over year.

Q1 2022 Guidance

GAAP revenue to be in the range of $385 million to $415 million, up 19 percent year over year at the midpoint

GAAP diluted EPS to be in the range of $0.13 to $0.27, up 17 cents year over year at the midpoint

Non-GAAP diluted EPS expected to be in the range of $0.35 to $0.49, up 31 percent year over year at the midpoint

Conference Call Information
NI management will discuss Q4 2021 results today, January 27, at 4:00 p.m. CT at www.ni.com/call or dial (855) 212-2361 and enter confirmation code 4276084. The call and an accompanying slide presentation will be webcast on the investor website, www.ni.com/nati, under “Events & Presentations.” Replay is available by calling (855) 859-2056, confirmation code 4276084 , shortly after the call through January 31, at 11:59 p.m. CT.

Non-GAAP Presentation
To supplement NI’s financial statements presented on a GAAP basis, NI has provided non-GAAP financial information, including non-GAAP revenue or net sales, gross profit, gross margin, operating expenses, operating income, operating margin, provision for income taxes, net income, net margin and diluted EPS. A reconciliation of the adjustments to GAAP results is included in the tables below. Non-GAAP financial information is not meant as a substitute for GAAP results, but is included because management believes such information is useful to our investors for informational and comparative purposes. In addition, certain non-GAAP financial information is used internally by management to evaluate and manage the company. The non-GAAP financial information used by NI may differ from that used by other companies. These non-GAAP measures should be considered in addition to, and not as a substitute for, the results prepared in accordance with GAAP.

Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 including without limitation those statements about our expectations of accelerating growth and progress to meet or exceed long-term financial model, our continued momentum across regions and business units, our opportunities to drive growth, profitability and efficiency in our business, confidence in our software strategy, our ability to drive growth through strategic changes made to our business, including the transition to subscription-based licensing model for software offerings, confidence in our investment strategy, our ability to successfully integrate acquisitions and execute our growth strategy, our ability to achieve sustainable customer demand through focus on secular growth opportunities, and our guidance and expectations for our Q1 2022 revenue, diluted EPS, backlog, lead times and gross margin. These statements are subject to a number of risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements.  Risks and uncertainties include without limitation: the effect of the global economic and geopolitical conditions; our international operations and foreign economies; adverse public health matters, including epidemics and pandemics such as the COVID-19 pandemic; our ability to effectively manage our partners and distribution channels; interruptions in our technology systems; cyber-attacks; the dependency of our product revenue on certain industries and the risk of contractions in such industries; fluctuations in demand for our products including orders from our large customers; concentration of credit risk and uncertain conditions in the global financial markets; our ability to compete in markets that are highly competitive; our ability to release successful new products or achieve expected returns; the risk that our manufacturing capacity and a substantial majority of our warehousing and distribution capacity are located outside of the U.S.; our dependence on key suppliers and distributors; component shortages; longer delivery lead times from our suppliers; risk of product liability claims; dependence on our proprietary rights and risks of intellectual property litigation; the continued service of key management and technical personnel; the ability to comply with environmental laws and associated costs; our ability to maintain our website; the risks of bugs, vulnerabilities, errors or design flaws in our products; our ability to achieve the benefits of employee restructuring plans; our exposure to large orders; our ability to effectively manage our operating expenses and meet budget; expense overruns; manufacturing inefficiencies and the level of capacity utilization; fluctuations in our quarterly results due to factors outside of our control; our outstanding debt; seasonal variation in our revenues; our ability to comply with laws and regulations; changes in tax rates and exposure to additional tax liabilities; our ability to make certain acquisitions or dispositions, integrate the companies we acquire or separate the companies we sold and/or enter into strategic relationships; risks related to currency fluctuations; adverse effects of price changes; and changes in accounting principles.  In addition, our ability to declare and/or pay declared dividends is subject to compliance with the terms of our existing credit agreement. The company directs readers to its Form 10-K for the year ended December 31, 2020, and the other documents it files with the SEC for other risks associated with the company’s future performance. These documents contain and identify important factors that could cause our actual results to differ materially from those contained in our forward-looking statements.

About NI
At NI, we bring together the people, ideas and technology so forward thinkers and creative problem solvers can take on humanity’s biggest challenges. From data and automation to research and validation, we provide the tailored, software-connected systems engineers and enterprises need to Engineer Ambitiously™ every day.

National Instruments, NI, ni.com and Engineer Ambitiously are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies. (NATI-F)


National Instruments
 
Condensed Consolidated Balance Sheets
 
(in thousands)
 
 
 
December 31,
   
December 31,
 
 
 
2021
   
2020
 
 
 
(unaudited)
       
ASSETS
           
Current assets:
           
Cash and cash equivalents
 
$
211,106
   
$
260,232
 
Short-term investments
   
     
59,923
 
Accounts receivable, net
   
341,275
     
266,869
 
Inventories, net
   
289,243
     
194,012
 
Prepaid expenses and other current assets
   
90,225
     
68,470
 
Total current assets
   
931,849
     
849,506
 
Property and equipment, net
   
253,668
     
254,399
 
Goodwill
   
583,589
     
467,547
 
Intangible assets, net
   
212,521
     
172,719
 
Operating lease right-of-use assets
   
58,641
     
67,674
 
Other long-term assets
   
74,717
     
72,643
 
Total assets
   
2,114,985
     
1,884,488
 
 
               
LIABILITIES AND EQUITY
               
Current liabilities:
               
Accounts payable and accrued liabilities
   
83,218
     
51,124
 
Accrued compensation
   
111,261
     
87,068
 
Deferred revenue
   
137,818
     
132,151
 
Operating lease liabilities
   
13,137
     
15,801
 
Other taxes payable
   
59,109
     
48,129
 
Debt - current
   
     
5,000
 
Other current liabilities
   
40,671
     
42,578
 
Total current liabilities
   
445,214
     
381,851
 
Debt - non-current
   
300,000
     
92,036
 
Deferred income taxes
   
14,249
     
25,288
 
Income tax payable - non-current
   
54,195
     
61,623
 
Deferred revenue - non-current
   
32,822
     
36,335
 
Operating lease liabilities - non-current
   
30,468
     
35,854
 
Other long-term liabilities
   
14,340
     
26,630
 
Total liabilities
   
891,288
     
659,617
 
 
               
Stockholders' equity:
               
Preferred stock
   
     
 
Common stock
   
1,323
     
1,312
 
Additional paid-in capital
   
1,129,647
     
1,033,284
 
Retained earnings
   
112,858
     
211,101
 
Accumulated other comprehensive loss
   
(20,131
)
   
(20,826
)
Total stockholders' equity
   
1,223,697
     
1,224,871
 
Total liabilities and stockholders' equity
 
$
2,114,985
   
$
1,884,488
 


National Instruments
 
Condensed Consolidated Statements of Income
 
(in thousands, except per share data, unaudited)
 
 
                 
 
 
Three Months Ended
   
Years Ended
 
 
 
December 31,
   
December 31,
 
 
 
2021
   
2020
   
2021
   
2020
 
 
                       
Net sales:
                       
Product
 
$
377,303
   
$
327,714
   
$
1,304,609
   
$
1,137,603
 
Software maintenance
   
43,338
     
40,124
     
165,072
     
149,068
 
Total net sales
   
420,641
     
367,838
     
1,469,681
     
1,286,671
 
 
                               
Cost of sales:
                               
Product
   
119,857
     
105,625
     
406,342
     
359,861
 
Software maintenance
   
3,739
     
3,571
     
14,621
     
11,260
 
Total cost of sales
   
123,596
     
109,196
     
420,963
     
371,121
 
 
                               
Gross profit
   
297,045
     
258,642
     
1,048,718
     
915,550
 
 
   
71%

   
70%

   
71%

   
71%

Operating expenses:
                               
Sales and marketing
   
122,304
     
134,570
     
467,352
     
465,509
 
Research and development
   
92,301
     
73,733
     
335,986
     
280,381
 
General and administrative
   
32,543
     
36,883
     
127,215
     
129,863
 
Total operating expenses
   
247,148
     
245,186
     
930,553
     
875,753
 
Gain on sale of business
   
     
     
     
159,753
 
Operating income
   
49,897
     
13,456
     
118,165
     
199,550
 
Other income (expense)
   
(4,739
)
   
1,797
     
(14,590
)
   
(788
)
Income before income taxes
   
45,158
     
15,253
     
103,575
     
198,762
 
Provision for income taxes
   
4,822
     
10,515
     
14,260
     
55,103
 
Net income
 
$
40,336
   
$
4,738
   
$
89,315
   
$
143,659
 
                                 
Basic earnings per share
 
$
0.31
   
$
0.04
   
$
0.68
   
$
1.10
 
Diluted earnings per share
 
$
0.30
   
$
0.04
   
$
0.67
   
$
1.09
 
 
                               
Weighted average shares outstanding -
                               
Basic
   
132,215
     
131,277
     
132,311
     
131,082
 
Diluted
   
133,225
     
131,732
     
133,562
     
131,799
 
 
                               
Dividends declared per share
 
$
0.27
   
$
0.26
   
$
1.08
   
$
1.04
 


National Instruments
 
Condensed Consolidated Statements of Cash Flows
 
(in thousands)
 
   
Years Ended December 31,
 
   
2021
   
2020
 
   
(unaudited)
       
Cash flow from operating activities:
           
Net income
 
$
89,315
   
$
143,659
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
   
99,402
     
87,064
 
Stock-based compensation
   
74,583
     
58,376
 
Disposal gain on sale of business/asset
   
     
(159,753
)
Loss from equity-method investees
   
5,719
     
2,942
 
Deferred income taxes
   
(15,796
)
   
7,771
 
Net change in operating assets and liabilities
   
(110,020
)
   
40,708
 
Net cash provided by operating activities
   
143,203
     
180,767
 
                 
Cash flow from investing activities:
               
Acquisitions, net of cash received
   
(222,783
)
   
(334,981
)
Proceeds from sale of assets/business, net of cash divested
   
     
160,266
 
Capital expenditures
   
(40,975
)
   
(49,652
)
Capitalization of internally developed software
   
(1,464
)
   
(4,054
)
Additions to other intangibles
   
(2,751
)
   
(1,441
)
Acquisitions of equity-method and other investments
   
(15,753
)
   
(9,761
)
Purchases of short-term investments
   
     
(206,330
)
Sales and maturities of short-term investments
   
60,297
     
384,652
 
Net cash used by investing activities
   
(223,429
)
   
(61,301
)
                 
Cash flow from financing activities:
               
Proceeds from term loan
   
     
170,000
 
Payments of term loan
   
(98,750
)
   
(71,250
)
Proceeds from revolving line of credit
   
300,000
     
20,000
 
Payments of revolving line of credit
   
     
(20,000
)
Debt issuance costs
   
(1,993
)
   
(1,893
)
Proceeds from issuance of common stock
   
32,518
     
31,947
 
Repurchase of common stock
   
(55,000
)
   
(48,713
)
Dividends paid
   
(143,113
)
   
(136,545
)
Net cash provided by (used by) financing activities
   
33,662
     
(56,454
)
                 
Impact of changes in exchange rates on cash
   
(2,562
)
   
2,604
 
                 
Net change in cash and cash equivalents
   
(49,126
)
   
65,616
 
Cash and cash equivalents at beginning of period
   
260,232
     
194,616
 
Cash and cash equivalents at end of period
 
$
211,106
   
$
260,232
 


The following tables provide details with respect to the amount of GAAP charges related to stock-based compensation, amortization of acquisition-related intangibles and fair value adjustments, acquisition-related transaction costs, disposal gains on sale of business/assets and related charitable contributions, tax effects related to businesses held-for-sale, capitalization and amortization of internally developed software costs, and restructuring charges that were recorded in the line items indicated below (unaudited) (in thousands):

   
Three Months Ended
   
Years Ended
 
   
December 31,
   
December 31,
 
   
2021
   
2020
   
2021
   
2020
 
Stock-based compensation
                       
Cost of sales
 
$
1,092
   
$
979
   
$
4,580
   
$
3,766
 
Sales and marketing
   
6,284
     
5,462
     
25,233
     
22,288
 
Research and development
   
5,811
     
5,129
     
23,515
     
17,769
 
General and administrative
   
5,335
     
4,251
     
21,384
     
14,552
 
Provision for income taxes
   
(2,010
)
   
(445
)
   
(12,047
)
   
(8,705
)
Total
 
$
16,512
   
$
15,376
   
$
62,665
   
$
49,670
 
                                 
Amortization of acquisition-related intangibles and fair value adjustments
                               
Net sales
 
$
352
   
$
1,961
   
$
2,324
   
$
3,260
 
Cost of sales
   
6,700
     
4,313
     
19,391
     
9,892
 
Sales and marketing
   
3,334
     
1,965
     
10,192
     
5,264
 
Research and development
   
320
     
9
     
320
     
94
 
General and administrative
   
     
846
     
     
846
 
Other expense (income)
   
531
     
124
     
2,007
     
487
 
Provision for income taxes
   
(1,626
)
   
(606
)
   
(4,071
)
   
(2,554
)
Total
 
$
9,611
   
$
8,612
   
$
30,163
   
$
17,289
 
                                 
Acquisition-related transaction and integration costs, restructuring charges, and other(1)(2)
                               
Cost of sales
 
$
25
   
$
1,620
   
$
(25
)
 
$
1,626
 
Sales and marketing
   
1,687
     
23,309
     
7,759
     
32,079
 
Research and development
   
9,682
     
1,184
     
11,104
     
6,374
 
General and administrative (1)
   
865
     
8,685
     
8,254
     
21,279
 
Gain on sale of business/asset (2)
   
     
     
     
(159,753
)
Other expense (income)
   
     
191
     
4,322
     
589
 
Provision for income taxes
   
(2,708
)
   
(1,602
)
   
(6,837
)
   
32,364
 
Total
 
$
9,551
   
$
33,387
   
$
24,577
   
$
(65,442
)
(1): During the third quarter of 2020, we recognized $5 million of compensation expense related to the replacement of unvested options acquired from OptimalPlus. These amounts were accounted for as post-combination expense and will be recognized over the required service period
 
(2): During the first quarter of 2020, we recognized a gain of $160 million related to the divestiture of AWR, presented within "Gain on sale of business/assets".
 
   
(Capitalization) and amortization of internally developed software costs
                               
Cost of sales
 
$
5,041
   
$
6,936
   
$
23,674
   
$
27,931
 
Research and development
   
(188
)
   
(1,248
)
   
(1,433
)
   
(4,043
)
Provision for income taxes
   
(1,085
)
   
(1,195
)
   
(4,877
)
   
(5,017
)
Total
 
$
3,768
   
$
4,493
   
$
17,364
   
$
18,871
 


National Instruments
 
Reconciliation of GAAP to Non-GAAP Measures
 
(in thousands, unaudited)
 
 
                       
   
Three Months Ended
   
Years Ended
 
   
December 31,
   
December 31,
 
   
2021
   
2020
   
2021
   
2020
 
Reconciliation of Net sales to Non-GAAP Net sales
                       
Net sales, as reported
 
$
420,641
   
$
367,838
   
$
1,469,681
   
$
1,286,671
 
Impact of acquisition related fair value adjustments
   
352
     
1,961
     
2,324
     
3,260
 
Non-GAAP net sales
 
$
420,993
   
$
369,799
   
$
1,472,005
   
$
1,289,931
 
                                 
Reconciliation of Gross Profit to Non-GAAP Gross Profit
                               
Gross profit, as reported
 
$
297,045
   
$
258,642
   
$
1,048,718
   
$
915,550
 
Stock-based compensation
   
1,092
     
979
     
4,580
     
3,766
 
Amortization of acquisition-related intangibles and fair value adjustments
   
7,052
     
6,274
     
21,715
     
13,152
 
Acquisition transaction and integration costs, restructuring charges and other
   
25
     
1,620
     
(25
)
   
1,626
 
Amortization of internally developed software costs
   
5,041
     
6,936
     
23,674
     
27,931
 
Non-GAAP gross profit
 
$
310,255
   
$
274,451
   
$
1,098,662
   
$
962,025
 
Non-GAAP gross margin
   
74%

   
74%

   
75%

   
75%

                                 
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses
                 
Operating expenses, as reported
 
$
247,148
   
$
245,186
   
$
930,553
   
$
875,753
 
Stock-based compensation
   
(17,430
)
   
(14,842
)
   
(70,132
)
   
(54,609
)
Amortization of acquisition-related intangibles and fair value adjustments
   
(3,654
)
   
(2,820
)
   
(10,512
)
   
(6,204
)
Acquisition transaction and integration costs, restructuring charges and other
   
(12,234
)
   
(33,178
)
   
(27,117
)
   
(59,732
)
Capitalization of internally developed software costs
   
188
     
1,248
     
1,433
     
4,043
 
Non-GAAP operating expenses
 
$
214,018
   
$
195,594
   
$
824,225
   
$
759,251
 
                                 
Reconciliation of Operating Income to Non-GAAP Operating Income
                 
Operating income, as reported
 
$
49,897
   
$
13,456
   
$
118,165
   
$
199,550
 
Stock-based compensation
   
18,522
     
15,821
     
74,712
     
58,375
 
Amortization of acquisition-related intangibles and fair value adjustments
   
10,706
     
9,094
     
32,227
     
19,356
 
Acquisition transaction and integration costs, restructuring charges and other
   
12,259
     
34,798
     
27,092
     
61,358
 
Net amortization of internally developed software costs
   
4,853
     
5,688
     
22,241
     
23,888
 
Gain on sale of business/assets
   
     
     
     
(159,753
)
Non-GAAP operating income
 
$
96,237
   
$
78,857
   
$
274,437
   
$
202,774
 
Non-GAAP operating margin
   
23%

   
21%

   
19%

   
16%

                                 
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes
                 
Provision for income taxes, as reported(1)
 
$
4,822
   
$
10,515
   
$
14,260
   
$
55,103
 
Stock-based compensation
   
2,010
     
445
     
12,047
     
8,705
 
Amortization of acquisition-related intangibles and fair value adjustments
   
1,626
     
606
     
4,071
     
2,554
 
Acquisition transaction and integration costs, restructuring charges and other
   
2,708
     
1,328
     
6,837
     
4,122
 
Net amortization of internally developed software costs
   
1,085
     
1,195
     
4,877
     
5,017
 
Gain on sale of business/assets
   
     
274
     
     
(36,486
)
Non-GAAP provision for income taxes(1)
 
$
12,251
   
$
14,363
   
$
42,092
   
$
39,015
 
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
 


Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income and Non-GAAP Diluted EPS
 
(in thousands, except per share data, unaudited)
 
 
                       
 
 
Three Months Ended
   
Years Ended
 
 
 
December 31,
   
December 31,
 
 
 
2021
   
2020
   
2021
   
2020
 
 
                       
Net income, as reported
 
$
40,336
   
$
4,738
   
$
89,315
   
$
143,659
 
Adjustments to reconcile net income to non-GAAP net income:
                               
Stock-based compensation
   
18,522
     
15,821
     
74,712
     
58,375
 
Amortization of acquisition-related intangibles and fair value adjustments
   
11,237
     
9,218
     
34,234
     
19,843
 
Acquisition transaction and integration costs, restructuring charges and other
   
12,259
     
34,989
     
31,414
     
61,947
 
Net amortization of internally developed software costs
   
4,853
     
5,688
     
22,241
     
23,888
 
Gain on sale of business/asset
   
     
     
     
(159,753
)
Income tax effects and adjustments(1)
   
(7,429
)
   
(3,848
)
   
(27,832
)
   
16,088
 
Non-GAAP net income
 
$
79,778
   
$
66,606
   
$
224,084
   
$
164,047
 
Non-GAAP net margin
   
18.9%

   
18.0%

   
15.2%

   
12.7%

 
                               
Diluted EPS, as reported
 
$
0.30
   
$
0.04
   
$
0.67
   
$
1.09
 
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS
                               
Stock-based compensation
   
0.14
     
0.12
     
0.56
     
0.44
 
Amortization of acquisition-related intangibles and fair value adjustments
   
0.09
     
0.07
     
0.26
     
0.15
 
Acquisition transaction and integration costs, restructuring charges and other
   
0.09
     
0.27
     
0.23
     
0.47
 
Net amortization of internally developed software costs
   
0.04
     
0.04
     
0.17
     
0.18
 
Gain on sale of business/asset
   
     
     
     
(1.21
)
Income tax effects and adjustments(1)
   
(0.06
)
   
(0.03
)
   
(0.21
)
   
0.12
 
Non-GAAP diluted EPS
 
$
0.60
   
$
0.51
   
$
1.68
   
$
1.24
 
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
 
 
                               
Weighted average shares outstanding
                               
Basic
   
132,215
     
131,277
     
132,311
     
131,082
 
Diluted
   
133,225
     
131,732
     
133,562
     
131,799
 



Reconciliation of GAAP to Non-GAAP Diluted EPS Guidance
 
(unaudited)
 
 
 
Three Months Ended
 
 
 
March 31, 2022
 
 
           
 
 
Low
   
High
 
GAAP Diluted EPS, guidance
 
$
0.13
   
$
0.27
 
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:
               
Stock-based compensation
   
0.15
     
0.15
 
Amortization of acquisition-related intangibles and fair value adjustments
   
0.10
     
0.10
 
Acquisition transaction and integration costs, restructuring charges and other
   
0.01
     
0.01
 
Net amortization of internally developed software costs
   
0.01
     
0.01
 
Income tax effects and adjustments(1)
   
(0.05
)
   
(0.05
)
Non-GAAP Diluted EPS, guidance
 
$
0.35
   
$
0.49
 
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.